Cbd Life Sciences Inc
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and… Read more
Market Cap & Net Worth: Cbd Life Sciences Inc (CBDL)
Cbd Life Sciences Inc (PINK:CBDL) has a market capitalization of $1.37 Million ($1.37 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #40523 globally and #13138 in its home market, demonstrating a -40.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cbd Life Sciences Inc's stock price $0.00 by its total outstanding shares 4555686228 (4.56 Billion).
Cbd Life Sciences Inc Market Cap History: 2015 to 2025
Cbd Life Sciences Inc's market capitalization history from 2015 to 2025. Data shows change from $265.69 Trillion to $1.37 Million (-87.32% CAGR).
Cbd Life Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cbd Life Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
20.92x
Cbd Life Sciences Inc's market cap is 20.92 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $13.66 Trillion | $2.57 Million | $1.26 Million | 5317701.40x | 10852605.13x |
| 2018 | $164.00 Billion | $703.89K | -$2.83 Million | 232996.64x | N/A |
| 2019 | $1.95 Billion | $79.64K | -$861.01K | 24541.84x | N/A |
| 2020 | $2.19 Billion | $225.90K | -$1.69 Million | 9680.21x | N/A |
| 2021 | $273.34 Million | $59.26K | -$5.13 Million | 4612.81x | N/A |
| 2022 | $68.34 Million | $160.24K | -$859.80K | 426.45x | N/A |
| 2023 | $68.34 Million | $167.15K | -$78.57K | 408.83x | N/A |
| 2024 | $2.28 Million | $108.89K | -$757.19K | 20.92x | N/A |
Competitor Companies of CBDL by Market Capitalization
Companies near Cbd Life Sciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Cbd Life Sciences Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cbd Life Sciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Cbd Life Sciences Inc's market cap moved from $265.69 Trillion to $ 1.37 Million, with a yearly change of -87.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.37 Million | -40.00% |
| 2024 | $2.28 Million | -96.67% |
| 2023 | $68.34 Million | 0.00% |
| 2022 | $68.34 Million | -75.00% |
| 2021 | $273.34 Million | -87.50% |
| 2020 | $2.19 Billion | +11.89% |
| 2019 | $1.95 Billion | -98.81% |
| 2018 | $164.00 Billion | -98.80% |
| 2017 | $13.66 Trillion | -88.89% |
| 2016 | $122.94 Trillion | -53.73% |
| 2015 | $265.69 Trillion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cbd Life Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.37 Million USD |
| MoneyControl | $1.37 Million USD |
| MarketWatch | $1.37 Million USD |
| marketcap.company | $1.37 Million USD |
| Reuters | $1.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.